Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Leonard J Appleman, MD, PhD
University of Pittsburgh
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Loyola University Chicago
Maywood, Illinois, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Dartmouth-Hitchcock Medical Center
Hanover, New Hampshire, United States
- the Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Providence Health & Services
Portland, Oregon, United States
- University of Pittsburgh Cancer Institute / Upmc Cancercenter
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2012
- Primary completion
- 6 Feb 2018
- Completion
- 28 Feb 2019
- Last update posted
- 2 Jan 2020
- Registered enrollment
- 30
- Registry id
- NCT01550367
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.